16 Dec 2018 | 12:18 PM
 

Aurobindo Pharma Ltd. Share Price Live (BSE)
0

BSE Code: 524804 | NSE Symbol: AUROPHARMA
726.80
-23.35
(-3.11 %)
14 Dec 2018 | 04:01 PM
Change company
  • Open (Rs)
    745.50
  • Prev. close (Rs.)
    750.15
  • High (Rs.)
    746.00
  • Low (Rs.)
    716.05
  • 52W H (Rs.)
    830.00
  • 52W L (Rs.)
    527.05
  • Volume
    222038
  • MCap (Rs in Cr.)
    42,583.80
728.15
-24.50
(-3.26 %)
  • Open (Rs)
    746.05
  • High (Rs)
    748.60
  • Low (Rs)
    717.40
  • Prev. close(Rs)
    752.65
  • Contracts Tra.
    1,05,79,000
  • Turnover (Cr.)
    773
  • Open Interest
    2,08,55,000
  • Open Int. chg
    15,17,000.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
41.36
Operating Margin (%)
22.91
Gross Profit Margin (%)
19.52
Net Profit Margin (%)
14.71
Total Debt/Equity
0.38
Dividend payout Ratio (Net Profit)
10.91
Earning Retention Ratio
89.08

News

11 Oct 2018 - 14:09:00-Drug firm Aurobindo Pharma Thursday said it has received final nod from the US health regulator for ...
18 Sep 2018 - 14:48:00-Aurobindo Pharma Limited has said that the company has received approval from the South Af...
06 Sep 2018 - 10:14:00-Shares of Aurobindo Pharma surged nearly 5 per cent on Bombay Stock Exchange after the drug maker sa...
06 Sep 2018 - 09:28:00-Aurobindo Pharma Limited a world-leading marketer and manufacturer of generic pharmaceutic...

Announcements

11-Dec-2018
Aurobindo Pharma - Updates
11-Dec-2018
Aurobindo Pharma - Announcement under Regulation 30 (LODR)-Joint Venture
06-Dec-2018
Aurobindo Pharma - News Verification
06-Dec-2018
Aurobindo Pharma - Clarification
06-Dec-2018
Aurobindo Pharma - Clarification sought from Aurobindo Pharma Ltd

Religare Research

14 Dec 2018 | 07:00 PM
Nifty recovered strongly last week and managed to gain over a percent. Almost all the sectors contri...
14 Dec 2018 | 06:00 PM
Markets rebounded sharply last week and reached closer to their crucial resistance again. Besides, p...
14 Dec 2018 | 11:48 AM
Highlights: Cooler weather in North-West India (being beneficial for Rabi crop sown), lack of stro...
14 Dec 2018 | 10:21 AM
Gold prices steady on Fed policy outlook uncertainty Oil surged higher as Saudis reportedly plan to ...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
94,96,996 715.12 52.21 0.44
94,96,996 715.12 618.37 0.44
94,96,996 715.12 648.72 0.45
94,96,996 715.12 55.57 0.45
48,31,294 363.80 475.12 0.37

Shareholding Pattern

       
Promotors51.87%
Mutual Funds/UTI14.53%
FI/Banks0.51%
Insurance0.51%
FII19.11%
Government0.00%
Others4.77%

Peer Group

Company Intraday Graph
 Abbott India Ltd.
7,528.80(0.33)
3280
 Sanofi India Ltd.
6,293.05(0.26)
3325
 Pfizer Ltd.
2,859.95(1.16)
3370
 Dr. Reddy`s Laboratories Ltd.
2,591.60(-0.17)
3294

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Aurobindo Pharma Ltd.-55.90-63.10116.90
NIFTY(S&P CNX)229.15-709.75-2.60
BSE SENSEX820.94-1,622.58363.11
BSE 500268.48-964.66-423.86

Corporate Details

Key Personal
Avnit Bimal Singh
Non Exe. & Ind. Director
D Rajagopala Reddy
Non Exe. & Ind. Director
K Nithyananda Reddy
Vice Chairman & Whole Time Dir
Key Address
Registered Office
Plot No.2 Maitri Vihar Ameerpet,Hyderabad,Telangana

Tel:040-23736370 66725000, Fax:040-23747340 67074059

info@aurobindo.com
http://www.aurobindo.com
Registrar Office
Karvy Fintech Pvt. Ltd.
Add. :Karvy Selenium Tower B Plot No. 31-32 Gachibowli Financial District Nanakramguda